Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development

26 Sept 2022

Abstract excerpt

Background: Poor prognosis, resistance to chemotherapy, insensitivity to radiotherapy, and a high prevalence of adverse drug reactions remain urgent issues for breast cancer (BC) patients. Increased knowledge of tumor immunobiology and vaccine development suggests the possibility of cancer vaccination. Here, we investigated potential BC-associated antigens for the development of an anti-BC mRNA vaccine and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immune cells in cancer
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36226063
DOI: 10.3389/fonc.2022.973712

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine developmentPMID 36226063Read ↗

Identification of novel tumor antigens and immune subtypes in breast cancer patients for mRNA vaccine developmentSemantic proximity Read ↗

Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell TranscriptomesSemantic proximity Read ↗

Transcriptomics and mutational analysis to screen immunogenic neoantigen peptides and Patient stratification based on immune subtypes for TNBCSemantic proximity Read ↗

Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune MicroenvironmentSemantic proximity Read ↗

A novel molecular subtype identification applied to individualized treatment of mRNA vaccines for hepatocellular carcinomaSemantic proximity Read ↗

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.Semantic proximity Read ↗

Identification of a novel immune-related gene signature by single-cell and bulk sequencing for the prediction of the immune landscape and prognosis of breast cancerSemantic proximity Read ↗

Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures.Semantic proximity Read ↗

Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune SubtypeSemantic proximity Read ↗

Prognostic Analysis of Patients with Breast Cancer Based on Tumor Mutational Burden, DNA Damage Repair Genes, and Immune InfiltrationSemantic proximity Read ↗

Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancerSemantic proximity Read ↗

Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.